Market Cap: $58.72M
XI
Xilio Therapeutics, Inc.
XLO
NASDAQ (NASDAQ Global Select)USD
Market Cap: $58.72M
Analysts estimated XLO earnings of $-0.60 per share this quarter (Q2). XLO's actual earnings were $-0.33 per share.
XLO EPS surprise of 44.62%Analysts estimated XLO earnings of $-0.67 per share this quarter (Q1). XLO's actual earnings were $-0.58 per share.
XLO EPS surprise of 12.99%Analysts estimated XLO earnings of $-1.70 per share this quarter (Q4). XLO's actual earnings were $0.81 per share.
XLO EPS surprise of 147.74%Analysts estimated XLO earnings of $-0.42 per share this quarter (Q3). XLO's actual earnings were $-0.08 per share.
XLO EPS surprise of 80.20%Analysts estimated XLO earnings of $-0.08 per share this quarter (Q2). XLO's actual earnings were $-0.16 per share.
XLO EPS surprise of -98.02%Analysts estimated XLO earnings of $0.10 per share this quarter (Q1). XLO's actual earnings were $-0.18 per share.
XLO EPS surprise of -153.33%Analysts estimated XLO earnings of $-0.22 per share this quarter (Q4). XLO's actual earnings were $-0.20 per share.
XLO EPS surprise of 8.59%Analysts estimated XLO earnings of $-0.25 per share this quarter (Q3). XLO's actual earnings were $-0.22 per share.
XLO EPS surprise of 11.68%Analysts estimated XLO earnings of $-0.11 per share this quarter (Q1). XLO's actual earnings were $-0.62 per share.
XLO EPS surprise of -458.06%Analysts estimated XLO earnings of $-0.82 per share this quarter (Q3). XLO's actual earnings were $-0.61 per share.
XLO EPS surprise of -25.21%